These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19301570)

  • 21. Regulation of progesterone signaling during pregnancy: implications for the use of progestins for the prevention of preterm birth.
    Byrns MC
    J Steroid Biochem Mol Biol; 2014 Jan; 139():173-81. PubMed ID: 23410596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of progesterone in maternal and fetal medicine.
    Di Renzo GC; Giardina I; Clerici G; Mattei A; Alajmi AH; Gerli S
    Gynecol Endocrinol; 2012 Nov; 28(11):925-32. PubMed ID: 23057618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravaginal use of natural micronised progesterone to prevent pre-term birth: a randomised trial in India.
    Majhi P; Bagga R; Kalra J; Sharma M
    J Obstet Gynaecol; 2009 Aug; 29(6):493-8. PubMed ID: 19697195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ACOG Committee Opinion number 419 October 2008 (replaces no. 291, November 2003). Use of progesterone to reduce preterm birth.
    Society for Maternal Fetal Medicine Publications Committee
    Obstet Gynecol; 2008 Oct; 112(4):963-5. PubMed ID: 18827143
    [No Abstract]   [Full Text] [Related]  

  • 25. Opinion & hypothesis could early aspirin prophylaxis prevent against preterm birth?
    Bujold E; Roberge S; Tapp S; Giguère Y
    J Matern Fetal Neonatal Med; 2011 Jul; 24(7):966-7. PubMed ID: 21303304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attitudes and practices regarding use of progesterone to prevent preterm births.
    Henderson ZT; Power ML; Berghella V; Lackritz EM; Schulkin J
    Am J Perinatol; 2009 Aug; 26(7):529-36. PubMed ID: 19301227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of spontaneous preterm birth: the role of sonographic cervical length in identifying patients who may benefit from progesterone treatment.
    Romero R
    Ultrasound Obstet Gynecol; 2007 Oct; 30(5):675-86. PubMed ID: 17899585
    [No Abstract]   [Full Text] [Related]  

  • 28. [Progesteron--an old--new option in the prevention of preterm birth].
    Rath W
    Z Geburtshilfe Neonatol; 2008 Aug; 212(4):125-6. PubMed ID: 18729034
    [No Abstract]   [Full Text] [Related]  

  • 29. Rationale for current and future progestin-based therapies to prevent preterm birth.
    Weatherborn M; Mesiano S
    Best Pract Res Clin Obstet Gynaecol; 2018 Oct; 52():114-125. PubMed ID: 29724668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progestin treatment for the prevention of preterm birth.
    Lucovnik M; Kuon RJ; Chambliss LR; Maner WL; Shi SQ; Shi L; Balducci J; Garfield RE
    Acta Obstet Gynecol Scand; 2011 Oct; 90(10):1057-69. PubMed ID: 21564026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of preterm birth: a renewed national priority.
    Damus K
    Curr Opin Obstet Gynecol; 2008 Dec; 20(6):590-6. PubMed ID: 18989136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antenatal progesterone to prevent preterm birth.
    Doyle LW
    Lancet; 2009 Jun; 373(9680):2000-2. PubMed ID: 19523682
    [No Abstract]   [Full Text] [Related]  

  • 33. Using 17 α-hydroxyprogesterone caproate to impact rates of recurrent preterm delivery in clinical practice.
    Rebarber A; Fox NS; Klauser CK; Istwan NB; Rhea DJ; Stanziano GJ; Saltzman DH
    J Matern Fetal Neonatal Med; 2010 Oct; 23(10):1139-42. PubMed ID: 20170407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reducing preterm births.
    Reprod Biomed Online; 2007 May; 14(5):663. PubMed ID: 17509212
    [No Abstract]   [Full Text] [Related]  

  • 35. Progesterone for preventing premature birth: practice patterns of board-certified maternal-fetal medicine specialists in the United States.
    Ness A; Baxter J; Hyslop T; Berghella V
    J Reprod Med; 2006 May; 51(5):411-5. PubMed ID: 16779989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preventing cervical ripening: the primary mechanism by which progestational agents prevent preterm birth?
    Xu H; Gonzalez JM; Ofori E; Elovitz MA
    Am J Obstet Gynecol; 2008 Mar; 198(3):314.e1-8. PubMed ID: 18313454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety signals of 17-OHP-C use in pregnancy and efficacy in the prevention of preterm birth.
    Calda P
    J Matern Fetal Neonatal Med; 2009 Jun; 22(6):540-2. PubMed ID: 19089768
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of progestogens in pregnant and infertile patients.
    Ozlü T; Güngör AC; Dönmez ME; Duran B
    Arch Gynecol Obstet; 2012 Aug; 286(2):495-503. PubMed ID: 22543698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical characteristics of women prescribed 17 alpha-hydroxyprogesterone caproate in the community setting.
    Rittenberg C; Sullivan S; Istwan N; Rhea D; Stanziano G; Newman R
    Am J Obstet Gynecol; 2007 Sep; 197(3):262.e1-4. PubMed ID: 17826412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A possible role for progesterone metabolites in human parturition.
    Sheehan PM
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):159-63. PubMed ID: 16638041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.